In late 2022, science delivered when we shared the stunning results of a five-year clinical trial for a groundbreaking new treatment regimen for people living with drug-resistant TB. Ahead in 2023, we are looking forward to seeing the benefits to people’s lives as the treatment is rolled out in MSF projects and beyond. Here is the story of Dilaram, a nurse from Uzbekistan, about her participation in the clinical trial and how it changed her life.